Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA), a pioneer in the field of synthetic biology, operates at the cutting edge of biotechnology. Headquartered in Boston, Massachusetts, the company is renowned for..
Sana Biotechnology, Inc. (NASDAQ: SANA) has captured the interest of investors with its innovative approach to cell engineering and a standout potential upside of 82.99%. Operating within the healthcare sector,..
Zenas BioPharma, Inc. (ZBIO), a clinical-stage biopharmaceutical company, has been capturing significant attention in the biotechnology sector with its focus on transformative immunology-based therapies. Headquartered in Waltham, Massachusetts, Zenas BioPharma..
Tourmaline Bio, Inc. (TRML) is making waves in the healthcare sector, particularly within the biotechnology industry. Based in New York, this clinical-stage company is focused on developing innovative treatments for..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector with a focus on medical devices, presents a compelling investment case with a potential upside of 30.51% according..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a biopharmaceutical company specializing in oncology therapies, has caught the attention of investors with a potential upside of 131.48%. This impressive figure is driven by..
ATAI Life Sciences N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector, particularly in the field of mental health treatments. With a market capitalization of $1.27 billion and a..
Kamada Ltd. (NASDAQ: KMDA), an Israeli-based healthcare company in the Drug Manufacturers – Specialty & Generic industry, is capturing investor attention with its significant upside potential. With a market capitalization..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is drawing attention from investors with its significant potential upside of 311.11%, according to current analyst ratings. With a market cap of..
Stoke Therapeutics, Inc. (NASDAQ: STOK) stands at the forefront of biotechnology innovation with a focus on severe genetic diseases. The company, which emerged in 2014 and rebranded in 2016, is..
Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, is garnering attention for its notable potential upside of 34.46%. As a company specializing in preparedness and response..
Nutex Health Inc. (NUTX) is making waves in the healthcare sector, particularly within the medical care facilities industry. With its headquarters in Houston, Texas, Nutex Health operates a diverse portfolio..
In the ever-evolving landscape of biotechnology, Arbutus Biopharma Corporation (NASDAQ: ABUS) emerges as a noteworthy contender with its focus on innovative therapeutics for infectious diseases. With a market capitalization of..
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, is making waves in the medical care facilities industry. Based in Dallas, Texas, Sonida operates senior housing communities..
Investors with a keen interest in biotech innovation should keep an eye on REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology firm pioneering gene therapies. With a market capitalization of $614.76..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors with its promising pipeline in the biotechnology sector. As a clinical-stage biopharmaceutical company, Oric is committed to developing therapies..
Prothena Corporation plc (NASDAQ: PRTA), a pioneering biotech entity headquartered in Dublin, Ireland, is making strategic strides in the healthcare sector, specifically within the biotechnology industry. With a current market..
Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, offers a compelling investment opportunity with a potential upside of 98.02%. This potential is driven by an..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is capturing the attention of investors with its promising outlook in the biotech sector. As a clinical-stage pharmaceutical company, Amylyx is focused on developing treatment..
Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the healthcare sector, specializes in molecular diagnostic testing and precision medicine. With a market capitalization of $720.17 million, this Salt Lake..
